|Articles|August 13, 2020
- Applied Clinical Trials-08-01-2020
- Volume 29
- Issue 7/8
Applied Clinical Trials, August 2020 Issue (PDF)
Click here for a link to open the Applied Clinical Trials August 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 5 years ago
Integration of Biomarker Validation in Oncology Trialsabout 5 years ago
Immunomodulators and Cancer Researchabout 5 years ago
COVID Exposes the Cracks in Trial Problemsabout 5 years ago
The RACE for Children Act Takes Effect This Monthabout 5 years ago
Designing Cell Therapies to Target Solid Tumorsabout 5 years ago
The Importance of Biomarker Managementabout 5 years ago
Clinical Trials Can Duck the European GMO Problemabout 5 years ago
Clinical Trial At-Home Service Providersabout 5 years ago
News Notesabout 5 years ago
Initial Design Considerations for Immuno-Oncology TrialsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
